Loading
Stemtech Corp Stock: price and insider trades · United States
US·Mcap US$237.2k
No insider purchase over the last 90 days. The latest, by ARNOLD CHARLES STUART, was filed 31 Jul 2024.
Stemtech Corp: what insiders have been doing
Stemtech Corp is a listed company. Filings by its managers are published through SEC (Form 4). Stemtech Corp has had no insider filing for more than a year; the last one goes back to 27 June 2025.
Other companies in the same market with recent insider buying flagged by our signals: Relmada Therapeutics, Inc. and Uber Technologies, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
6
Thresholds
n/a
Buy Volume
€1,152
1 ops. · all time
Sell Volume
€27,370
2 ops. · all time
Who traded when
BuySaleBenjamin Nathaniel Kaplan1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.00
Analyst consensus
Income statement
RevenueUS$2.9M
Gross profitUS$2.3M80% margin
EBITDA-US$2.4M-84% margin
Net income-US$4M-155.5% margin
Valuation
Beta2.58
Balance sheet & cash
Market capUS$237.2k
Total debtUS$4.2M
Free Cash Flow-US$483.6k
Profitability & ownership
ROA-46.4%
% insiders10.5%
% institutions0.0%
Last declaration on 27 June 2025
Declarations6 total
1,000,000 shares@ US$0.03100.0% of flowCommon StockSEC:0001096906-25-001055:0
25,000 shares@ US$0.05100.0% of flowCOMMON - CREST VENTURES LLCSEC:0001683168-24-005182:0
Canonical exit: 24 Oct 2024 (T+90)
25,000 shares@ US$0.0641100.0% of flowCommon StockSEC:0001493152-24-015605:0
1,254,818 shares@ US$0.0533.8% of flowCOMMONSEC:0001683168-23-005428:0
2,408,818 shares@ US$0.0566.2% of flowCommon StockSEC:0001683168-23-004588:0
8,333,333 shares@ €0.046599.7% of flowCOMMONSEC:0001683168-23-004586:0
6 of 6 declarations
About Stemtech Corp
Stemtech Corp is a company focused on developing health products based on stem cells. It is listed on the XNAS market.
